American Heart Journal
Volume 156, Issue 6 , Pages 1170-1176 , December 2008

Cholesterol levels and in-hospital mortality in patients with acute decompensated heart failure

  • Tamara B. Horwich, MD, MS

      Affiliations

    • Ahmanson-UCLA Cardiomyopathy Center, University of California, Los Angeles, CA
    • ,
  • Adrian F. Hernandez, MD, MHS

      Affiliations

    • Duke Clinical Research Institute, Durham, NC
    • ,
  • David Dai, PhD

      Affiliations

    • Duke Clinical Research Institute, Durham, NC
    • ,
  • Clyde W. Yancy, MD

      Affiliations

    • Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, TX
    • ,
  • Gregg C. Fonarow, MD

      Affiliations

    • Ahmanson-UCLA Cardiomyopathy Center, University of California, Los Angeles, CA
    • Corresponding Author InformationReprint requests: Gregg C. Fonarow, MD, Ahmanson-UCLA Cardiomyopathy Center, UCLA Medical Center, 10833 LeConte Ave, Room 47-123 CHS, Los Angeles, CA 90095-1679.
    • ,
  • for the Get With the Guidelines Steering Committee and Hospitals

Received 22 May 2008 ,Accepted 5 July 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This study was funded by the American Heart Association (Dallas, TX) with support from an unrestricted educational grant from GlaxoSmithKline (Philadelphia, PA). Dr Horwich is supported by the National Institutes of Health 1K23HL085097 (Bethesda, MD). Dr Hernandez is a recipient of an American Heart Association Pharmaceutical Roundtable grant (0675060N) and a research support from GlaxoSmithKline. Dr Horwich has no funding/support to disclose; Dr Dai is an employee of Duke Clinical Research Institute (Durham, NC); Drs Yancy and Fonarow engage in research and are consultants in GlaxoSmithKline and received honorarium from the same company; Dr Fonarow is the chair of the Get With the Guidelines Steering Committee, and holds the Eliot Corday Chair in Cardiovascular Medicine and Science.

PII: S0002-8703(08)00571-1

doi: 10.1016/j.ahj.2008.07.004

American Heart Journal
Volume 156, Issue 6 , Pages 1170-1176 , December 2008

Article Tools

* Image Usage & Resolution